Health
Moderna’s Flu Vaccine Set for FDA Review
Moderna's mRNA flu vaccine candidate is set to undergo review by an FDA advisory panel. The company had initially faced some delays.
Coverage timeline — 1 article
The Hill
Presented by Coalition to Strengthen America’s Healthcare {beacon} Health Care Health Care The Big Story Moderna’s mRNA flu shot to get FDA review After some initial back-and-forth, Moderna’s candidate for a mRNA flu vaccine will get a review by a Food and Drug Administration (FDA) advisory panel
2026-05-22 22:52 UTC